ArticlebioRxiv : the preprint server for biology2023

Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality.

Santosh Karnewar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.